Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Jul;30(1-3):85-93.
doi: 10.1023/A:1008012518961.

Modification of glucose and glutamine metabolism in hybridoma cells through metabolic engineering

Affiliations

Modification of glucose and glutamine metabolism in hybridoma cells through metabolic engineering

C Paredes et al. Cytotechnology. 1999 Jul.

Abstract

The present work describes the genetic modification of a hybridoma cell line with the aim to change its metabolic behaviour, particularly reducing the amounts of ammonia and lactate produced by the cells. The cellular excretion of ammonia was eliminated by transfection of a cloned glutamine synthetase gene. The metabolic characterisation of the transformed cell line includes the analysis of the changes introduced in its intracellular metabolic fluxes by means of a stoichiometric model. Furthermore, the reduction of lactate accumulation was attempted through an antisense mRNA approach, aiming to generate a rate limiting step in the glycolytic pathway, thus lowering the glucose consumption rate. The physiological results obtained with the transformed cells are discussed. A maximum reduction of about 47% in the glucose consumption rate was obtained for one of the transformations. However a main drawback was the lack of stability of the transformed cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, Albright LM, Coen DM, Varki A, editors. Current protocols in molecular biology. New York: John Wiley & Sons Inc.; 1997.
    1. Bebbington CR, Renner G, Thompson S, King D, Abrams D, Yarranton GT. High-level expression of a recombinant antibody from myeloma cells using a glutamine synthetase gene as an amplifiable selectable marker. Bio/Technology. 1990;10:169–175. doi: 10.1038/nbt0292-169. - DOI - PubMed
    1. Bell SL, Bebbington CR, Scott MF, Wardell JN, Spier RE, Bushell ME, Sanders PG. Genetic Engineering of Hybridoma Glutamine Metabolism. Enzyme Microb Technol. 1995;17:98–106. doi: 10.1016/0141-0229(94)00056-W. - DOI - PubMed
    1. Birch JR, Boraston RC, Metcalfe H, Brown ME, Bebbington CR, Field RP. Selecting and Designing Cell Lines for Improved Physiological Characteristics. Cytotechnol. 1994;15:11–16. doi: 10.1007/BF00762375. - DOI - PubMed
    1. Birnbaum MJ. Identification of a novel gene encoding an insulin-responsive glucose transporter protein. Cell. 1989;57:305–315. doi: 10.1016/0092-8674(89)90968-9. - DOI - PubMed